Drug Profile
Eliprodil
Alternative Names: SL 820715Latest Information Update: 11 Jun 2002
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Anti-ischaemics; Nootropics; Piperidines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; Craniocerebral trauma; Multiple sclerosis; Stroke
Most Recent Events
- 11 Jun 2002 Discontinued - Phase-III for Head injuries in European Union (unspecified route)
- 11 Jun 2002 Discontinued - Phase-III for Head injuries in USA (unspecified route)
- 11 Jun 2002 Discontinued - Phase-III for Stroke in European Union (unspecified route)